Genzyme Australasia Home Genzyme Corporate Home Search Contact Us Genzyme Websites
About GenzymeOur Treatement AreasHealthcare Professionals
Genzyme

Our Therapies and Products
Gaucher Disease
Fabry Disease
MPS I
MPS II
(Hunter Syndrome)
Thyroid Cancer
Renal Disease
Osteoarthritis
Abdominal Surgeries

About End Stage Renal Disease

Approximately 225,000 people in Europe, 300,000 people in the United States and one million worldwide suffer from end-stage renal disease (ESRD) and depend on haemodialysis to replace their kidney function. ESRD occurs when a significant portion of normal kidney function is lost. Healthy kidneys concentrate waste materials in the urine, maintain fluid (water) balance, manufacture vitamin D, stimulate red blood cell production, and maintain good bone and cardiac health by controlling serum phosphorus levels.

For more information about Renal disease contact your doctor or other healthcare professional.

This site is intended for use by Australian and New Zealand residents only.




Highlight

GRIP – Unravelling kidney disease

Genzyme Renal Innovations Programme (GRIP) invites submissions for 2009 research awards. Read full press release.


  Contact Us:

Level 1, Building C,
12-24 Talavera Road
North Ryde NSW 2113
P: 612 9978 3900
F: 612 9889 3900

Mailing Address:
PO Box 282
North Ryde B/C NSW 1670
General Email
Medical Enquiries Email

Terms and Conditions of Use | Privacy Policy | © 2003-2010 Genzyme Corporation. All rights reserved.